Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01062022 · ClinicalTrials.gov registry record · NA
FOCUS-CI: A Preventive Intervention With Children and Families of the Combat Injured
A NA study, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT01062022: Clinical Trial NA study, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
NCT01062022 is a NA study that was terminated before completion, run by Henry M. Jackson Foundation for the Advancement of Military Medicine. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01062022, a NA study, was terminated before completion, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to implement a unique evidence-based intervention program to help military families deal with the critical issue of combat injury and its impact on current and future family health and functioning. The study is a randomized study. The study will compare the effects of the newly designed FOCUS-CI (Families OverComing Under Stress - Combat Injury) with the existing standard of care (SoC) at three military medical rehabilitation sites (Walter Reed Amry Medical Center, Brooke Army Medical Center and Madigan Army Medical Center) on key aspects of family health and functioning.
Interventions
- BEHAVIORAL Standard of Care
- BEHAVIORAL FOCUS-CI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2011-01 |
| Est. Completion | 2014-11 |
| Phase | NA |
Why NCT01062022 stopped before completion
NCT01062022 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT01062022 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01062022 about?
NCT01062022 is a clinical study titled "FOCUS-CI: A Preventive Intervention With Children and Families of the Combat Injured". The purpose of this study is to implement a unique evidence-based intervention program to help military families deal with the critical issue of combat injury and its impact on current and future family health and functioning. The study is a randomized study. The study will compare the effects of th...
What is the current status of trial NCT01062022?
This trial is currently terminated. It is a NA study. The enrollment target is 23 participants. The study started on 2011-01. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01062022?
The interventions under investigation include: Standard of Care (BEHAVIORAL), FOCUS-CI (BEHAVIORAL).
Who is sponsoring clinical trial NCT01062022?
This trial is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01062022's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia